Cadre Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cadre Holdings Inc 's ROA in the third quarter of 2026?
Cadre Holdings inc achieved a return on average assets (ROA) of 4.72 % in its third quarter of 2026, which is below Cadre Holdings Inc 's average return on assets, which stands at 5.06%.

ROA has improved compared to 4.3% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 164 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 1228 to 1269.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	16.33 %	15.85 %	34.5 %	18.55 %	28.42 %
Y / Y Net Income Change	46.1 %	-6.58 %	-78.64 %	-9.58 %	199.34 %
Net Income (TTM) in million	41	36	37	44	45
Return On Assets (TTM)	4.72 %	4.3 %	4.56 %	5.87 %	6.29 %
CDRE's Total Ranking	# 1269	# 1228	# 993	# 1085	# 1031
Total Assets (TTM) in million	919	917	880	770	790
Seq. Total Assets Change	0.17 %	4.27 %	14.25 %	-2.51 %	-0.24 %
Seq. Net Income Change	40.13 %	477.57 %	-83.18 %	7.29 %	-10.4 %

CDRE's 5 Years Annual ROA >> Back to CDRE Management Effectiveness >> Compare CDRE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 46
Sector	# 165
Overall	# 1303

Return On Assets Statistics
High	Average	Low
9.42 %	5.06 %	-2.56 %
(Dec 31 2023)		(Jun 30 2022)

Financial Statements
Cadre Holdings Inc 's Assets	$ 919 million	CDRE's Balance sheet
Cadre Holdings Inc 's Income	$ 16 million	Quarterly CDRE's Income Statement
CDRE's Income by Division		See CDRE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	18.55 %	51.18 %	10 %	27.76 %	-
Total Assets in million	770	650	430	391	306
Y / Y Net Income Change	22.16 %	-6.49 %	563.93 %	-54.03 %	-
Net Income in million	44	36	39	6	13
Annual Return On Assets	5.73 %	5.56 %	8.99 %	1.49 %	4.14 %

CDRE's 5 Years Annual ROA >> Back to CDRE Management Effectiveness >> Compare CDRE ROA to its Competitors

Comment on CDRE's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 5.73 % compared to prior year, due to annual net income growth of 22.16 % to $44.14 million, while value of Cadre Holdings Inc 's overall assets grew just by 18.55 % to $770.03 million, compared to $770.03 a year before.

More Return On Assets Ratios
CDRE's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CDRE's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CDRE's Competitors
Subscribers only: Roa for Cadre Holdings Inc 's Suppliers
Subscribers only: Return On Assets for CDRE's Customers

You may also want to know
CDRE's Roi	CDRE's Inventory Turnover Ratio	CDRE's Growth Rates	CDRE's Dividend Comparisons
	CDRE's Profitability Ratios	CDRE's Asset Turnover Ratio	CDRE's Dividend Growth
CDRE's Roe	CDRE's Valuation Ratios	CDRE's Financial Strength Ratios	CDRE's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Beone Medicines Ltd	10.23 %
Amgen Inc	10.02 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %

Date modified: 2026-11-06T13:05:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.